TY - CHAP AU - Norton, L. AU - Day, R. PY - 1991 DA - 1991// TI - Potential innovations in scheduling cancer chemotherapy. BT - In: Important Advances in Oncology. Edited by deVita V, Hellman S, Rosenberg S. Philadelphia: JB Lippincott Company; ID - Norton1991 ER - TY - JOUR AU - Barnes, D. M. AU - Miles, D. W. PY - 2000 DA - 2000// TI - Response of metastatic breast cancer to trastuzumab? JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(99)00430-4 DO - 10.1016/S0140-6736(99)00430-4 ID - Barnes2000 ER - TY - JOUR AU - Peters, W. P. AU - Shpall, E. J. AU - Jones, R. B. AU - Olsen, G. A. AU - Bast, R. C. AU - Gockerman, J. P. AU - Moor, J. O. PY - 1988 DA - 1988// TI - High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer. JO - J Clin Oncol VL - 6 ID - Peters1988 ER - TY - JOUR AU - Peters, W. P. AU - Ross, M. AU - Vredenburgh, J. J. AU - Meisenberg, B. AU - Marks, L. B. AU - Winer, E. AU - Kurtzberg, J. AU - Bast, R. C. AU - Jones, R. AU - Shpall, E. PY - 1993 DA - 1993// TI - High dose chemotherapy and autologous bone marrow support as consolidation after standard dose adjuvant chemotherapy for high-risk primary breast cancer. JO - J Clin Oncol VL - 11 ID - Peters1993 ER - TY - JOUR AU - Rodenhuis, S. AU - Richel, D. J. AU - van der Wall, E. AU - Schornagel, J. H. AU - Baars, J. W. AU - Koning, C. C. E. AU - Peterse, J. AU - Borger, J. H. AU - Nooijen, W. J. AU - Dalesio, O. AU - Rutgers, E. PY - 1998 DA - 1998// TI - Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph node involvement. JO - Lancet VL - 352 UR - https://doi.org/10.1016/S0140-6736(98)01350-6 DO - 10.1016/S0140-6736(98)01350-6 ID - Rodenhuis1998 ER - TY - JOUR AU - Hortobagyi, G. N. AU - Buzdar, A. U. AU - Theriault, R. L. AU - Valero, V. AU - Frye, D. AU - Booser, D. H. AU - Holmes, F. A. AU - Giralt, S. AU - Khouri, I. AU - Andersson, B. AU - Gajewski, J. L. AU - Rondon, G. AU - Smith, T. L. AU - Singletary, S. E. AU - Ames, F. C. AU - Sneige, N. AU - Strom, E. A. AU - McNeese, M. D. AU - Deisseroth, A. B. AU - Champlin, R. E. PY - 2000 DA - 2000// TI - Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. JO - J Natl Cancer Inst VL - 92 UR - https://doi.org/10.1093/jnci/92.3.225 DO - 10.1093/jnci/92.3.225 ID - Hortobagyi2000 ER - TY - JOUR AU - Peters, W. AU - Rosner, G. AU - Vredenburgh, J. AU - Shpall, E. AU - Crump, M. AU - Richardson, P. AU - Marks, L. AU - Cirrincione, C. AU - Wood, W. AU - Henderson, I. AU - Hurd, D. AU - Norton, L. PY - 1999 DA - 1999// TI - A prospective, randomised comparison of two doses of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes (LN): Preliminary results of CALBG9082/SWOG 9114/NCIC MA-13 [abstract]. JO - Proc Am Soc Clin Oncol VL - 18 ID - Peters1999 ER - TY - STD TI - The Scandinavian Breast Cancer Study 9401: Results from a randomised adjuvant breast cancer study with high dose chemotherapy with CTCb, supported by autologous bone marrow stem cells versus dose escalated and tailored FEC therapy [abstract]. Proc Am Soc Clin Oncol. 1999, 18: 2a- ID - ref8 ER - TY - JOUR AU - Bezwoda, W. R. AU - Seymour, L. AU - Dansey, R. PY - 1995 DA - 1995// TI - High-dose chemotherapy with haematopoietic rescue as primary treatment for metastatic breast cancer: a randomised trial. JO - J Clin Oncol VL - 13 ID - Bezwoda1995 ER - TY - JOUR AU - Bezwoda, W. R. PY - 1998 DA - 1998// TI - Primary and high dose chemotherapy for metastatic breast cancer: update and analysis of prognostic features [abstract]. JO - Proc Am Soc Clin Oncol VL - 17 ID - Bezwoda1998 ER - TY - JOUR AU - Bezwoda, W. R. PY - 1999 DA - 1999// TI - Randomised controlled trial of high-dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer [abstract]. JO - Eur J Cancer VL - 35(suppl 4) UR - https://doi.org/10.1016/S0959-8049(99)81322-7 DO - 10.1016/S0959-8049(99)81322-7 ID - Bezwoda1999 ER - TY - JOUR AU - Bezwoda, W. R. PY - 1999 DA - 1999// TI - Randomised controlled trial of high-dose chemotherapy (HD-CNVp) versus standard (CAF) chemotherapy for high-risk, surgically treated, primary breast cancer [abstract]. JO - Proc Am Soc Clin Oncol VL - 18 ID - Bezwoda1999 ER - TY - JOUR AU - Weiss, R. B. AU - Rifkin, R. M. AU - Stewart, F. M. AU - Theriault, R. L. AU - Williams, L. A. AU - Herman, A. A. AU - Beveridge, R. A. PY - 2000 DA - 2000// TI - High dose chemotherapy for high risk primary breast cancer: an on-site review of the Bezwoda study. JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)90024-2 DO - 10.1016/S0140-6736(00)90024-2 ID - Weiss2000 ER - TY - JOUR AU - Bergh, J. PY - 2000 DA - 2000// TI - Where next with stem-cell-supported high-dose therapy for breast cancer? JO - Lancet VL - 355 UR - https://doi.org/10.1016/S0140-6736(00)90007-2 DO - 10.1016/S0140-6736(00)90007-2 ID - Bergh2000 ER - TY - JOUR AU - Lippman, M. E. PY - 2000 DA - 2000// TI - High-dose chemotherapy plus autologous bone marrow transplantation for metastatic breast cancer. JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200004133421508 DO - 10.1056/NEJM200004133421508 ID - Lippman2000 ER - TY - JOUR AU - Bonadonna, G. AU - Valagussa, P. AU - Moliterni, A. AU - Zambetti, M. AU - Brambilla, C. PY - 1995 DA - 1995// TI - Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node positive breast cancer: the results of 20 years of follow-up. JO - N Engl J Med VL - 332 UR - https://doi.org/10.1056/NEJM199504063321401 DO - 10.1056/NEJM199504063321401 ID - Bonadonna1995 ER - TY - JOUR AU - Hryniuk, W. AU - Bush, H. PY - 1984 DA - 1984// TI - The importance of high dose intensity in chemotherapy of metastatic breast cancer. JO - J Clin Oncol VL - 2 ID - Hryniuk1984 ER - TY - JOUR AU - Hrynuik, W. AU - Levine, M. N. PY - 1986 DA - 1986// TI - Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer. JO - J Clin Oncol VL - 4 ID - Hrynuik1986 ER - TY - JOUR AU - Wood, W. C. AU - Budman, D. R. AU - Korzun, H. AU - Robert, C. o. o. p. e. r. AU - Younger, J. AU - Hart, R. D. AU - Moore, A. AU - Ellerton, J. A. AU - Norton, L. AU - Ferree, C. R. AU - Ballow, A. C. AU - Frei, E. AU - Craig Henderson, I. PY - 1994 DA - 1994// TI - Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast carcinoma. JO - N Engl J Med VL - 330 UR - https://doi.org/10.1056/NEJM199405053301801 DO - 10.1056/NEJM199405053301801 ID - Wood1994 ER - TY - JOUR AU - Fossati, R. AU - Confalonieri, C. AU - Torri, V. AU - Ghislandi, E. AU - Penna, A. AU - Pistotti, V. AU - Tinazzi, A. AU - Liberati, A. PY - 1998 DA - 1998// TI - Cytotoxic and hormonal treatment for metastatic breast cancer a systematic review of published randomised trials involving 31,510 women. JO - J Clin Oncol VL - 16 ID - Fossati1998 ER - TY - JOUR AU - Stadtmauer, E. A. AU - O'Neill, A. AU - Goldstein, L. J. AU - Crilley, P. A. AU - Mangan, K. F. AU - Ingle, J. N. AU - Brodsky, I. AU - Martino, S. AU - Lazarus, H. M. AU - Erban, J. K. AU - Sickles, C. AU - Glick, J. H. PY - 2000 DA - 2000// TI - Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous haematopoietic stem cell transplant group. JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200004133421501 DO - 10.1056/NEJM200004133421501 ID - Stadtmauer2000 ER - TY - JOUR AU - Lotz, J. P. AU - Cure, H. AU - Janvier, M. AU - Morvan, F. AU - Asselain, B. AU - Guillemot, M. AU - Laadem, A. AU - Maraninchi, D. AU - Gisselbrecht, C. AU - Roche, H. PY - 1999 DA - 1999// TI - High-dose chemotherapy (HD-CT) with haemopoietic stem cell transplantation (HSCT) for metastatic breast cancer (MBC): results of the French Protocol PEGASE 04 [abstract]. JO - Proc Am Soc Clin Oncol VL - 18 ID - Lotz1999 ER - TY - JOUR AU - Day, R. PY - 1986 DA - 1986// TI - Treatment sequencing, asymmetry, and uncertainty: protocol strategies for combination chemotherapy. JO - Cancer Res VL - 46 ID - Day1986 ER - TY - JOUR AU - Goldie, J. H. AU - Coldman, A. J. PY - 1979 DA - 1979// TI - A mathematical model for relating the drug sensitivity of tumours to their spontaneous mutation rate. JO - Cancer Treatment Reports VL - 63 ID - Goldie1979 ER -